• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/29

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

29 Cards in this Set

  • Front
  • Back
Abacavir
ABC
NRTI, Guanosine analog
test for HLA-B*5701 --> hypersensitivity rxn
2nd line as drug #2/3 (in combo with lamivudine)
Tenofovir
TDF (supplied as Tenofovir Disoproxil Fumarate)
NRTI, Adenosine analog
1st line as drug #2/3 (in combo with emtricitabine)
renal impairment, decrease bone density (give Ca and Vit.D)
Emtricitabine
FTC (FluoroThioCytidine)
NRTI, Cytidine analog
1st line with tenofovir as drug #2/3
Lamivudine
3TC (3'-ThiaCytidine)
NRTI, Cytidine analog
2nd line as drug #2/3 in combo with zidovudine
Didanosine
ddI
NRTI, Adenosine analog
30min before/2hr after meal
not used much (toxicities)
GI intolerance, pancreatitis, peripheral neuropathy
Raltegravir
RAL
Integrase Inhibitor
1st line as drug #1
Ritonavir
RTV
Protease Inhibitor but only used to boost other PI's.
Most potent CYP3A4 inhibitor ever
GI intolerance, hepatitis
Atazanavir
ATV
PI
increased bilirubin, kidney stones, kidney dysfxn
first line as drug #1 (+ritonavir)
Darunavir
DRV
PI
take with food
caution: SJS
first line as drug #1 (+ritonavir)
Efavirenz
EFV
NNRTI
1st line as drug #1
CNS SEs--> take without food
Zidovudine
AZT (AZidoThymidine)
NRTI
Thymidine analog
2nd line as drug #2/3 (in combo with lamuvidine)
HA, GI intolerance, bone marrow suppression, myopathy
Etravirine
ETR
NNRTI
second line
disperse in water
Lopinavir
LPV
PI (preferred PI in pregnant women)
GI intolerance, kidney
2nd line as drug #1 (+ ritonavir)
Nevirapine
NVP
NNRTI
2nd line as drug #1
hepatotoxicity (may be severe/life-threatening), rash including SJS
Nelfinavir
PI
diarrhea
Maraviroc
MVC
CCR5 receptor antagonist; entry inhibitor
CYP 3A4 substrate
2nd line as drug #1
Enfurvitide
T20
Fusion inhibitor
injection site rxns, hypersensitivity
not used much
RIlpivirine
NNRTI
1 of 3 drugs in Complera
take with full meal (>500 cal)
do not take with acid suppression therapy
QT prolongation
Truvada
(components)
emtricitabine 200mg + tenofovir 300mg
2 x NRTI
Atripla
(components)
efavirenz 600mg + emtricitabine 200mg + tenofovir 300mg
EFV + Truvada
NNRTI + (2x NRTI)
Complera
(components)
rilpivirine + tenofovir + emtricitabine
(rilpivirine + Truvada)
NNRTI + (2 x NRTI)
ART associated ADRs?
lactic acidosis
hepatic steatosis
fat maldistribution
hyperlipidemia
osteonecrosis/penia/porosis
rash
NRTIs
abacavir
tenofovir
didanosine
zidovudine
emtricitabine
lamivudine
NNRTIs
efavirenz
etravirine
nevirapine
rilpiverine
PIs
atazanavir
lopinavir
nelfinavir
ritonavir
darunavir
fusion inhibitors
enfuvirtide
CCR5 antagonist
maraviroc
integrase inhibitors
raltegravir
Prophylacyic Regimens
Bacterial:
-pneumococcal: prevnar 13
-MAC: azithromycin 1200 mg once weekly if CD4 <50
Fungal: Candida, PCP - septra ss 1 tab daily (CD4 <200)
Parasitic: toxoplas - septra ss 1 tab daily (CD4 <100)
Viral: hep A/B vaccine if sero-ve